Chest guidelines will create debate over which antiplatelet drug to add to aspirin after an acute coronary syndrome

May 2012

New Chest guidelines will create debate over which antiplatelet drug to add to aspirin after an acute coronary syndrome.

These patients usually get clopidogrel (Plavix, etc)...but now guidelines suggest Brilinta (ticagrelor) over clopidogrel.

Brilinta is more effective...with a similar bleeding risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote